BREAK IN TRANCRIPT
Mr. PITTS. Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I rise today to support H.R. 733, the Recalcitrant Cancer Research Act of 2012.
This act will bring new hope to patients with cancers.
It is never easy to lose someone to cancer, but it is especially difficult when you are not even given a fighting chance.
Cancers with low survival rates and poor outcomes have baffled researchers for more than 40 years. These are recalcitrant cancers.
While survival rates for many cancers have climbed from 50 percent to 67 percent, there are still cancers that have yet to reach the 50 percent benchmark.
While there are various types of cancers that fall under this definition, nearly half of the 577,190 cancer deaths expected in 2012 will be caused by eight deadly cancers, including pancreatic and ovarian cancer.
This bill will direct the National Cancer Institute to establish a scientific framework for the study of recalcitrant cancers. Working groups will be appointed to prepare the framework that will include a review of current research and identification of key research questions and a summary of promising discoveries. The NIH would then be required to issue a report to Congress with recommendations on the effectiveness of the scientific framework model so that we can ensure that progress is being made and determine whether this type of model should be expanded to other types of diseases and conditions.
I urge my colleagues to vote in support of the legislation, and I reserve the balance of my time.
BREAK IN TRANSCRIPT
Mr. PITTS. Mr. Speaker, in conclusion, I want to commend the advocacy of Mr. Lance and Ms. Eshoo, the leadership, Mr. Upton, the ranking member of the full committee and the subcommittee, and thank the staffs of both the subcommittee and the full committee for their tireless work in putting together this bipartisan compromise, an excellent bill. And I urge support from the Members for H.R. 733, the Recalcitrant Cancer Research Act of 2012.
I yield back the balance of my time.
BREAK IN TRANSCRIPT